|
Geisinger Imp |
CRS (Chronic Rhinosinusitis) |
Geisinger |
Case, Control |
221 |
2,648 |
|
|
|
CRC implementation-Columbia |
Colorectal Cancer (CRC) |
Columbia University |
Case, Control |
1 |
2,789 |
|
|
|
RA_Columbia |
Rheumatoid Arthritis (RA) |
Columbia University |
Case, Control |
8 |
2,793 |
|
|
|
VU Implementation |
Gastroesophageal Reflux Disease (GERD) Phenotype Algorithm |
Vanderbilt University |
Case, Control |
1,642 |
2,862 |
|
|
|
Appendicitis Implementation - Columbia |
Appendicitis |
Columbia University |
Case, Control |
21 |
3,038 |
|
|
|
Autism Implementation - Columbia |
Autism |
Columbia University |
Case, Control |
|
3,084 |
|
|
|
Epilepsy Phenotype Case and Control |
Epilepsy/Antiepileptic drug response algorithm |
KPWHRI |
Case, Control |
23 |
3,282 |
|
|
|
NU T1DM PRS implementation |
Type 1 Diabetes |
Northwestern University |
Case, Control |
63 |
3,632 |
|
|
|
Harvard CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
|
Case, Control |
140 |
3,961 |
|
|
|
RA for NU GWAS population |
Rheumatoid Arthritis (RA) |
Northwestern University |
Case, Control |
96 |
3,987 |
|
|
|
Marshfield Implementation 2 |
CAAD (Carotid Artery Atherosclerosis Disease) |
Marshfield Clinic Research Foundation |
Case, Control |
193 |
4,170 |
100%, 100% |
|
|
Harvard CKD Implementation |
Chronic Kidney Disease |
|
Case, Control |
8,192 |
4,177 |
|
|
|
KPWA/UW (primary site) implementation |
Depression |
Kaiser Permanente of Washington Health Research Institute |
Case, Control |
1,999 |
4,268 |
|
|
|
KPWA/UW (primary site) implementation |
Depression |
KPWA/UW |
Case, Control |
1,999 |
4,268 |
100%, 100% |
100%, 100% |
|
NAFLD Implementation_Columbia |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
Columbia University |
Case, Control |
24 |
4,371 |
|
|
|
KPWA/UW (primary site) implementation |
Ovarian/Uterine Cancer (OvUtCa) |
KPWA/UW |
Case, Control |
73 |
4,425 |
|
|
|
Group Health/University of Washington CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Group Health/University of Washington |
Case, Control |
300 |
4,475 |
96%, 100% |
|
|
Mayo Clinic eMERGE III Implementation |
Clostridium Difficile Colitis |
Mayo Clinic |
Case, Control |
103 |
4,494 |
|
|
|
Vanderbilt CAAD Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Vanderbilt University |
Case, Control |
128 |
4,571 |
|
|
|
Network Combined Dataset - Diverticulosis |
Diverticulosis and Diverticulitis |
|
Case, Control |
6,173 |
4,969 |
|
|
|
Mount Sinai Implementation |
CAAD (Carotid Artery Atherosclerosis Disease) |
Mount Sinai School of Medicine |
Case, Control |
105 |
5,180 |
|
|
|
NAFLD KPWA |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
KPWA/UW |
Case, Control |
383 |
5,236 |
|
|
|
Geisinger Impl |
Migraine |
Geisinger |
Case, Control |
762 |
5,266 |
|
|
|
Harvard - AID Implementation |
Autoimmune Disease Phenotype |
|
Case, Control |
6,298 |
5,389 |
|
|
|
Harvard Migraine Implementation |
Migraine |
|
Case, Control |
647 |
5,734 |
|
|
